Linda Schwimmer, president and CEO of the New Jersey Health Care Quality Institute, discussed the impact of data on lowering the state’s C-section rates, which are among the highest in the country.
Linda Schwimmer, president and CEO of the New Jersey Health Care Quality Institute, discussed the impact of data on lowering the state’s C-section rates, which are among the highest in the country.
Transcript
High C-section rates have been a problem in New Jersey. How are hospitals and physicians using payment reform to address this problem?
New Jersey, unfortunately, has some of the highest C-section rates in the country; this is even in the case of what we would describe as “avoidable” situations, where it’s a first-time mother, the head is down, it’s a single birth. One of the reasons we even know that is because of the use of data in a transparent way done by the Leapfrog Group, which the New Jersey Health Care Quality Institute is very involved in. We are the local leader of that organization here in New Jersey. Just having that data and creating an awareness of what those rates are and then sharing those rates with physicians and nurses and showing them what their rate is, is one huge step forward that is happening now that the Quality Institute is part of.
The next step is changing the payment system, and putting into place models that will reward better outcomes. So the marriage between the data and the payment system is really where New Jersey needs to go, and I would say we’re in the early stages of that.
In these early stages, has any payer in New Jersey tried a model to reward providers for bringing down C-Section rates?
Horizon Blue Cross Blue Shield (of New Jersey) for their commercial population has had a model called an episode of care that’s been going on for a number of years. They are now just starting to take steps to develop that for the Medicaid plan. The New Jersey Health Care Quality Institute is convening all the health plans and many of the hospital systems that are providing maternity care for most of the Medicaid population, and together along with physicians and nurse midwives we are designing an episode-of-care model to supporter better outcomes for women and children, to reduce C-sections, to reduce NICU stays, and to do better when it comes to low birth weight. It’s really a collaborative process that is happening from outside the government, but we’re hoping it’s something that will be adopted by the Medicaid program moving forward.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More